345 related articles for article (PubMed ID: 28127549)
1. A Systematic Framework for Drug Repositioning from Integrated Omics and Drug Phenotype Profiles Using Pathway-Drug Network.
Jadamba E; Shin M
Biomed Res Int; 2016; 2016():7147039. PubMed ID: 28127549
[TBL] [Abstract][Full Text] [Related]
2. MD-Miner: a network-based approach for personalized drug repositioning.
Wu H; Miller E; Wijegunawardana D; Regan K; Payne PRO; Li F
BMC Syst Biol; 2017 Oct; 11(Suppl 5):86. PubMed ID: 28984195
[TBL] [Abstract][Full Text] [Related]
3. A network based approach to drug repositioning identifies plausible candidates for breast cancer and prostate cancer.
Chen HR; Sherr DH; Hu Z; DeLisi C
BMC Med Genomics; 2016 Jul; 9(1):51. PubMed ID: 27475327
[TBL] [Abstract][Full Text] [Related]
4. Systematic drug repositioning for a wide range of diseases with integrative analyses of phenotypic and molecular data.
Iwata H; Sawada R; Mizutani S; Yamanishi Y
J Chem Inf Model; 2015 Feb; 55(2):446-59. PubMed ID: 25602292
[TBL] [Abstract][Full Text] [Related]
5. PS4DR: a multimodal workflow for identification and prioritization of drugs based on pathway signatures.
Emon MA; Domingo-Fernández D; Hoyt CT; Hofmann-Apitius M
BMC Bioinformatics; 2020 Jun; 21(1):231. PubMed ID: 32503412
[TBL] [Abstract][Full Text] [Related]
6. Repositioning drugs by targeting network modules: a Parkinson's disease case study.
Yue Z; Arora I; Zhang EY; Laufer V; Bridges SL; Chen JY
BMC Bioinformatics; 2017 Dec; 18(Suppl 14):532. PubMed ID: 29297292
[TBL] [Abstract][Full Text] [Related]
7. Prediction of drug gene associations via ontological profile similarity with application to drug repositioning.
Kissa M; Tsatsaronis G; Schroeder M
Methods; 2015 Mar; 74():71-82. PubMed ID: 25498216
[TBL] [Abstract][Full Text] [Related]
8. Predicting Potential Drugs for Breast Cancer based on miRNA and Tissue Specificity.
Yu L; Zhao J; Gao L
Int J Biol Sci; 2018; 14(8):971-982. PubMed ID: 29989066
[TBL] [Abstract][Full Text] [Related]
9. Inferring new drug indications using the complementarity between clinical disease signatures and drug effects.
Jang D; Lee S; Lee J; Kim K; Lee D
J Biomed Inform; 2016 Feb; 59():248-57. PubMed ID: 26707452
[TBL] [Abstract][Full Text] [Related]
10. Network mirroring for drug repositioning.
Park S; Lee DG; Shin H
BMC Med Inform Decis Mak; 2017 May; 17(Suppl 1):55. PubMed ID: 28539121
[TBL] [Abstract][Full Text] [Related]
11. Drug repositioning by applying 'expression profiles' generated by integrating chemical structure similarity and gene semantic similarity.
Tan F; Yang R; Xu X; Chen X; Wang Y; Ma H; Liu X; Wu X; Chen Y; Liu L; Jia X
Mol Biosyst; 2014 May; 10(5):1126-38. PubMed ID: 24603772
[TBL] [Abstract][Full Text] [Related]
12. An integrated network platform for contextual prioritization of drugs and pathways.
Segura-Cabrera A; Singh N; Komurov K
Mol Biosyst; 2015 Nov; 11(11):2850-9. PubMed ID: 26315485
[TBL] [Abstract][Full Text] [Related]
13. Mining heterogeneous network for drug repositioning using phenotypic information extracted from social media and pharmaceutical databases.
Yang CC; Zhao M
Artif Intell Med; 2019 May; 96():80-92. PubMed ID: 31164213
[TBL] [Abstract][Full Text] [Related]
14. DrugNet: network-based drug-disease prioritization by integrating heterogeneous data.
MartÃnez V; Navarro C; Cano C; Fajardo W; Blanco A
Artif Intell Med; 2015 Jan; 63(1):41-9. PubMed ID: 25704113
[TBL] [Abstract][Full Text] [Related]
15. Drug repositioning for diabetes based on 'omics' data mining.
Zhang M; Luo H; Xi Z; Rogaeva E
PLoS One; 2015; 10(5):e0126082. PubMed ID: 25946000
[TBL] [Abstract][Full Text] [Related]
16. Drug Repositioning for Alzheimer's Disease Based on Systematic 'omics' Data Mining.
Zhang M; Schmitt-Ulms G; Sato C; Xi Z; Zhang Y; Zhou Y; St George-Hyslop P; Rogaeva E
PLoS One; 2016; 11(12):e0168812. PubMed ID: 28005991
[TBL] [Abstract][Full Text] [Related]
17. DrPOCS: Drug Repositioning Based on Projection Onto Convex Sets.
Wang YY; Cui C; Qi L; Yan H; Zhao XM
IEEE/ACM Trans Comput Biol Bioinform; 2019; 16(1):154-162. PubMed ID: 29993698
[TBL] [Abstract][Full Text] [Related]
18. Drug Repositioning through Systematic Mining of Gene Coexpression Networks in Cancer.
Ivliev AE; 't Hoen PA; Borisevich D; Nikolsky Y; Sergeeva MG
PLoS One; 2016; 11(11):e0165059. PubMed ID: 27824868
[TBL] [Abstract][Full Text] [Related]
19. An integrative approach using real-world data to identify alternative therapeutic uses of existing drugs.
Hosomi K; Fujimoto M; Ushio K; Mao L; Kato J; Takada M
PLoS One; 2018; 13(10):e0204648. PubMed ID: 30300381
[TBL] [Abstract][Full Text] [Related]
20. Integrating Clinical Phenotype and Gene Expression Data to Prioritize Novel Drug Uses.
Paik H; Chen B; Sirota M; Hadley D; Butte AJ
CPT Pharmacometrics Syst Pharmacol; 2016 Nov; 5(11):599-607. PubMed ID: 27860440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]